SYNAPTICS Inc
Financial highlights
| Metric | FY 06/28/25 | FY 06/29/24 | FY 06/24/23 | FY 06/25/22 | FY 06/26/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.1B | $959.4M | $1.4B | $1.7B | $1.3B |
| Cost of revenue | $593.9M | $519.6M | $639.2M | $796.6M | $728.4M |
| Gross profit | $480.4M | $439.8M | $715.9M | $943.1M | $611.2M |
| Selling, general & administrative | $180.3M | $161.3M | $175.0M | $168.4M | $144.9M |
| Research and development | $346.8M | $336.3M | $351.2M | $367.3M | $313.4M |
| Operating expenses | $574.5M | $541.4M | $561.6M | $592.7M | $464.2M |
| Operating income | -$94.1M | -$101.6M | $154.3M | $350.4M | $147.0M |
| Interest expense | $39.8M | $65.3M | $55.5M | $30.2M | $29.5M |
| Pretax income | -$113.5M | -$124.6M | $126.0M | $320.5M | $120.1M |
| Income tax expense | -$65.7M | -$250.2M | $52.4M | $64.6M | $31.4M |
| Net income | -$47.8M | $125.6M | $73.6M | $257.5M | $79.6M |
| Balance Sheet | |||||
| Cash and equivalents | $391.5M | $876.9M | $924.7M | $824.0M | $836.3M |
| Current assets | $751.9M | $1.2B | $1.3B | $1.4B | $1.2B |
| Total assets | $2.6B | $2.8B | $2.6B | $2.9B | $2.2B |
| Current liabilities | $270.9M | $277.2M | $260.1M | $463.4M | $786.7M |
| Total liabilities | $1.2B | $1.4B | $1.4B | $1.6B | $1.3B |
| Total debt | $850.0M | $983.5M | — | — | — |
| Stockholders' equity | $1.4B | $1.5B | $1.2B | $1.3B | $967.2M |
| Cash Flow Statement | |||||
| Cash from operations | $142.0M | $135.9M | $331.5M | $462.7M | $319.2M |
| Depreciation and amortization | $28.9M | $27.6M | $27.4M | $24.0M | $21.6M |
| Stock-based compensation | $112.8M | $118.8M | $122.0M | $100.8M | $66.1M |
| Capital expenditure | $25.8M | $33.8M | $34.2M | $31.1M | $21.1M |
| Free cash flow | $116.2M | $102.1M | $297.3M | $431.6M | $298.1M |
| Share repurchases | $128.3M | $0 | $183.5M | $0 | $0 |
| Impairments | $13.8M | $16.0M | $0 | $0 | $0 |
Shares outstanding 38.6M · Free float 99.5%
Annual filing data through FY ended June 28, 2025; float as of July 11, 2026.